Rob Stein Rob Stein is a Correspondent and Senior Editor on NPR's Science Desk.
Rob Stein, photographed for NPR, 22 January 2020, in Washington DC.
Stories By

Rob Stein

Mike Morgan/NPR
Rob Stein, photographed for NPR, 22 January 2020, in Washington DC.
Mike Morgan/NPR

Rob Stein

Correspondent and Senior Editor, Science Desk

Rob Stein is a correspondent and senior editor on NPR's science desk.

An award-winning science journalist with more than 30 years of experience, Stein mostly covers health and medicine. He tends to focus on stories that illustrate the intersection of science, health, politics, social trends, ethics, and federal science policy. He tracks genetics, stem cells, cancer research, women's health issues, and other science, medical, and health policy news.

Before NPR, Stein worked at The Washington Post for 16 years, first as the newspaper's science editor and then as a national health reporter. Earlier in his career, Stein spent about four years as an editor at NPR's science desk. Before that, he was a science reporter for United Press International (UPI) in Boston and the science editor of the international wire service in Washington.

Stein's work has been honored by many organizations, including the National Academy of Sciences, the American Association for the Advancement of Science, the American Association for Cancer Research, and the Association of Health Care Journalists. He was twice part of NPR teams that won Peabody Awards.

Stein frequently represents NPR, speaking at universities, international meetings and other venues, including the University of Cambridge in Britain, the World Conference of Science Journalists in South Korea, and the Aspen Institute in Washington, DC.

Stein is a graduate of the University of Massachusetts, Amherst. He completed a journalism fellowship at the Harvard School of Public Health, a program in science and religion at the University of Cambridge, and a summer science writer's workshop at the Marine Biological Laboratory in Woods Hole, Mass.

Story Archive

This year's holiday season is making infectious disease doctors very nervous

  • Download
  • <iframe src="https://www.npr.org/player/embed/1139388779/1139388780" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

From left: 1) Colored scanning electron micrograph (SEM) of a human cell infected with H3N2 flu virus (gold filamentous particles). 2) Scanning electron micrograph of human respiratory syncytial virus (RSV) virions (colorized blue) that are shedding from the surface of human lung epithelial cells. 3) Transmission electron micrograph of SARS-CoV-2 Omicron virus particles (gold). Science Source/ NIAID hide caption

toggle caption
Science Source/ NIAID

Experts are concerned Thanksgiving gatherings could accelerate a 'tripledemic'

  • Download
  • <iframe src="https://www.npr.org/player/embed/1137649962/1138728411" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

These two omicron subvariants could be the source of another COVID surge

  • Download
  • <iframe src="https://www.npr.org/player/embed/1134238924/1134238925" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Respiratory syncytial virus surges each winter, but this year it's early

  • Download
  • <iframe src="https://www.npr.org/player/embed/1131825886/1131825887" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Two new research papers cast doubt on the new COVID booster

  • Download
  • <iframe src="https://www.npr.org/player/embed/1131449380/1131449381" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

An electron microscope image shows a SARS-CoV-2 particle isolated in the early days of the pandemic. It's been nearly a year since omicron was first detected, and scientists say this branch of the coronavirus family tree is still thriving. NIAID/NIH via AP hide caption

toggle caption
NIAID/NIH via AP

Omicron keeps finding new evolutionary tricks to outsmart our immunity

  • Download
  • <iframe src="https://www.npr.org/player/embed/1129196088/1131279359" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The FDA authorizes omicron boosters for kids as young as 5 years old

  • Download
  • <iframe src="https://www.npr.org/player/embed/1128522562/1128522563" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The new bivalent COVID-19 booster is offered by the Los Angeles County Department of Public Health. Health experts say getting more people boosted could help stave off a winter COVID surge. Sarah Reingewirtz/ MediaNews Group/ Los Angeles Daily News via Getty Images hide caption

toggle caption
Sarah Reingewirtz/ MediaNews Group/ Los Angeles Daily News via Getty Images

Early signs a new U.S. COVID surge could be on its way

  • Download
  • <iframe src="https://www.npr.org/player/embed/1127017062/1127400876" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

The CDC wants you to get a flu shot before what could be a bad flu season

  • Download
  • <iframe src="https://www.npr.org/player/embed/1126806839/1126806840" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Gustavo Perez got his influenza vaccine from pharmacist Patricia Pernal in early September during an event hosted by the Chicago Department of Public Health at the city's Southwest Senior Center. This year's flu season may strike earlier and harder than usual, experts warn. A flu shot's your best protection. Scott Olson/ Getty Images hide caption

toggle caption
Scott Olson/ Getty Images

Pfizer and Moderna seek authorization of omicron booster for kids ages 5-11

  • Download
  • <iframe src="https://www.npr.org/player/embed/1125173003/1125173004" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Health officials are predicting this winter could see an active flu season on top of potential COVID surges. In short, it's a good year to be a respiratory virus. Left: Image of SARS-CoV-2 omicron virus particles (pink) replicating within an infected cell (teal). Right: Image of an inactive H3N2 influenza virus. NIAID/Science Source hide caption

toggle caption
NIAID/Science Source

Flu is expected to flare up in U.S. this winter, raising fears of a 'twindemic'

  • Download
  • <iframe src="https://www.npr.org/player/embed/1124311571/1124662880" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

President Joe Biden removes his face mask as he walks on the South Lawn of the White House in Washington, DC, on August 24, 2022. OLIVIER DOULIERY/AFP via Getty Images hide caption

toggle caption
OLIVIER DOULIERY/AFP via Getty Images

A pharmacist prepares to administer COVID-19 vaccine booster shots during an event hosted by the Chicago Department of Public Health at the Southwest Senior Center on September 09, 2022 in Chicago, Illinois. Scott Olson/Getty Images hide caption

toggle caption
Scott Olson/Getty Images

How Biden's declaring the pandemic 'over' complicates efforts to fight COVID

  • Download
  • <iframe src="https://www.npr.org/player/embed/1123883468/1124008627" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript

Biden's remarks that the pandemic is over hurts efforts to save lives, experts say

  • Download
  • <iframe src="https://www.npr.org/player/embed/1123926762/1123926763" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript